Journal: Advanced Science

Article Title: Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

doi: 10.1002/advs.76816

Figure Lengend Snippet: Langerhans cells migrate toward the wound during re‐epithelization. (A) Revisit multi‐photon in vivo microscopy images of a 1 mm wound from the same mouse. Image shows x‐y view of epithelial cells (red nuclei) and LCs (green) in the epidermis. Dashed line indicates initial wound boundary. Left : Day of wound induction (Day 0). Middle : 5 days after wound induction. Right : zoomed view of the wound center at Day 5. Representative images from 3 mice. Scale bars, 100 µm. (B) Time‐lapse image of epithelial cells (red nuclei) and LCs (green) 2 days after wound induction. Dashed line, initial wound boundary. Solid line, basal membrane separating epidermis from dermis. Top : x‐y view. Bottom : x‐z view shows the epidermis (red) and dermis (collagen SHG, blue). Representative images from 3 mice. Scale bars, 100 µm. (C) Imaris track analysis of LCs (B) 2 days after wound induction. Colors project time (blue, 0 h; red, 6 h). Top : x‐y view. Bottom : x‐z view. Representative images from 3 mice. Scale bars, 100 µm. (D) Top : zoomed migration tracks from (C). The green frame is from the wound leading‐edge epithelial migration zone, and the teal frame is from the epithelial proliferation zone . Middle : time‐lapse frames show the movement of individually colored LCs across 6 h. Epithelial cell nuclei in gray. Other LCs in white. Bottom : vector arrows show the general movement direction of the matching color LC. Representative images from 3 mice. Scale bars, 100 µm. (E) Mean total displacement of individual LC tracks over 6 h plotted as a function of distance from the wound. n = 3 mice. (F) Mean track displacement in the x axis of individual LC tracks over 6 h plotted as a function of distance from the wound. Calculated by comparing the start and end values in the x axis of each track. Positive change indicates movement toward the wound. n = 3 mice. (E,F) Imaging performed 2 days after wound induction. Dashed line, initial wound boundary. The displacements of migrating cell tracks were averaged every 100 µm from the initial wound. Data are mean ± s.d. (G) Imaris cell count analysis of LCs (spots) at Day 0 ( left ) and 5 days after wound induction ( right ). Dashed lines separate LCs into 3 zones: wound (yellow spots), near (0–400 µm from the wound edge, green spots), and far (400‐700 µm from the wound edge, teal spots). Epithelial cell nuclei are shown in gray. Representative images from 3 mice. Scale bars, 100 µm. (H) Mean LC number comparing cell density between Day 0 and 5 days after wound induction according to the 3 zones established in (G). n = 3 mice. (I) Mean LC number comparing the cell density change from the addition of the wound and near zones between Day 0 and 5 days after wound induction ( left bars ). Total change in LC density across all 3 zones between Day 0 and 5 days after wound induction ( right bars ). n = 3 mice. (H,I) Data analyzed using paired two‐way ANOVA; data are mean ± s.d. with each dot representing individual mice. *** p < 0.001, **** p < 0.0001.

Article Snippet: Samples were then enriched for LCs by magnetic sorting following the standard protocol from the Epidermal Langerhans Cell MicroBead Kit (Miltenyi Biotec).

Techniques: In Vivo, Microscopy, Membrane, Migration, Plasmid Preparation, Imaging, Cell Characterization

Journal: Advanced Science

Article Title: Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

doi: 10.1002/advs.76816

Figure Lengend Snippet: Langerhans cell mobility is independent of epithelial cell migration. (A) Time‐lapse x‐y view of epithelial cells (red nuclei) and LCs (green) 2 days after wound induction. Top : control mouse. Bottom : Epi‐ Rac1 KO mouse. Dashed line indicates initial wound boundary. Representative images from 3 mice per group. Scale bars, 100 µm. (B) Imaris x‐y view track analysis of LCs (A) 2 days after wound induction. Colors project time (blue, 0 h; red, 6 h). Top : control mouse. Bottom : Epi‐ Rac1 KO mouse. Right : zoomed migration tracks from near the wound edge. Dashed line indicates initial wound boundary. Representative images from 3 mice per group. Scale bars, 100 µm. (C) Mean total displacement of individual epithelial cell tracks from control and Epi‐ Rac1 KO mice over 6 h plotted as a function of distance from the wound. n = 3 mice per group (D) Mean total displacement of individual LC tracks from control and Epi‐ Rac1 KO mice over 6 h plotted as a function of distance from the wound. n = 3 mice per group C,D, Imaging performed 2 days after wound induction. Dashed line, initial wound boundary. The displacements of migrating cell tracks were averaged every 100 µm from the initial wound. Data analyzed using unpaired two‐way ANOVA; data are mean ± s.d. * p < 0.05. (E) In‐vivo microscopy images shows x‐y view of epithelial cells (red nuclei) and LCs (green) in the epidermis 5 days after wound induction. Dashed line indicates initial wound boundary. Left : control mouse and LC‐ Rac1 KO mouse. Right : zoomed view of the wound center from 5 days after wound induction. Representative images from 4 mice per group. Scale bars, 200 µm. (F) Mean LC number inside the wound epidermis from control and LC‐ Rac1 KO mice. Imaging was performed 5 days after wound induction. LC density normalized to the individual mouse wound area quantified. Data analyzed using unpaired two‐tailed t ‐test; n = 4 mice per group; data are mean ± s.d. with each dot representing individual mice. **** p < 0.0001.

Article Snippet: Samples were then enriched for LCs by magnetic sorting following the standard protocol from the Epidermal Langerhans Cell MicroBead Kit (Miltenyi Biotec).

Techniques: Migration, Control, Imaging, In Vivo, Microscopy, Two Tailed Test

Journal: Advanced Science

Article Title: Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

doi: 10.1002/advs.76816

Figure Lengend Snippet: Langerhans cell density changes during the remodeling phase. (A) Revisit multi‐photon in vivo microscopy images of a 1 mm wound from the same mouse. Images show x‐y view of epithelial cells (red nuclei) and LCs (green) in the epidermis at 0, 5, 15 days, and 6 weeks after wound induction. Dashed line indicates initial wound boundary. Left : zoomed view of the wound center. Right : revisit images showing the classification of several zones according to their distance from the wound: wound, near, middle, and far. Representative images from 6 mice. Scale bars, 100 µm. (B) Mean LC number comparing cell density changes within designated zones established in (A) at 0, 5, 15 days, and 6 weeks after wound induction. n = 6 mice. (C) Timeline of LC number comparing cell density changes between the wound and near zones. n = 6 mice. (B,C) Data analyzed using unpaired two‐way ANOVA; data are mean ± s.d. * p < 0.05, ** p < 0.01. (D) Time‐lapse image in x‐y view of proliferative LCs (green) at 7 days after wound induction. Dermis SHG collagen is shown in gray. Red dashed circles indicate diving LCs. (E) Time‐lapse frames from yellow highlighted area in (D) show LC division across 5 h. White arrows indicate actively diving LC. (D,E) Representative images from 3 mice. White dashed circle/line indicates initial wound boundary. Scale bars, 50 µm. (F) Confocal immunofluorescent images of cell proliferation at the wound epidermis 7 days after wound induction. Images show x‐y view of LCs (green, MHC‐II), proliferation (red, Ki67), and cell nuclei (blue, DAPI). Left : composite image. Middle : MHC‐II and Ki67 positive cells. Right : zoomed example of proliferative LC. MHC‐II, major histocompatibility complex class II. White arrows show proliferative cells. White arrowheads show proliferative LCs. Representative images from 4 mice. The white dashed line indicates the initial wound boundary. Scale bars, 50 µm. (G) Timeline of mean proliferative (Ki67+) cell density at the wound during healing ( n = 3 mice) and in homeostasis ( n = 6 mice). (H) Timeline of percentage of proliferative LCs (MHC‐II+Ki67+) at the wound during healing ( n = 3 mice) and in homeostasis ( n = 6 mice). (I) Confocal immunofluorescent images of cell apoptosis at the wound epidermis 3 weeks after wound induction. Images show x‐y view of LCs (green, MHC‐II), apoptosis (red, CC3), and cell nuclei (blue, DAPI). Left : composite image. Middle : MHC‐II and CC3 positive cells. Right : zoomed example of apoptotic LC. CC3, cleaved caspase‐3. The white arrow shows an apoptotic cell. White arrowhead shows an apoptotic LC. Representative images from 4 mice. The white dashed line indicates the initial wound boundary. Scale bars, 50 µm. (J) Mean number of apoptotic cells (CC3+) and apoptotic LCs (CC3+MHC‐II+) at the wound 3 weeks after wound induction. n = 3 mice. (K) Percentage of apoptotic LCs (CC3+MHC‐II+) during homeostasis and at 3 weeks after wound induction. n = 3 mice. (J,K) Wound area quantified 0.49 mm 2 per mouse. Data analyzed using unpaired one‐way ANOVA; data are mean ± s.d. with each dot representing individual mice. * p < 0.05, **** p < 0.0001.

Article Snippet: Samples were then enriched for LCs by magnetic sorting following the standard protocol from the Epidermal Langerhans Cell MicroBead Kit (Miltenyi Biotec).

Techniques: In Vivo, Microscopy, Immunopeptidomics

Journal: Advanced Science

Article Title: Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

doi: 10.1002/advs.76816

Figure Lengend Snippet: Multiple sources of Langerhans cells repopulate the wound site. (A) Experimental design of dual‐labeled LC mouse line. Dual‐labeled LC mice received daily tamoxifen injections 5 days prior to wound induction. Embryonic LCs (eLCs) are labeled yellow and progenitor‐derived LCs are only green. (B) Revisit multi‐photon in vivo microscopy images of a 1 mm wound from the same mouse. Images show x‐y view of epithelial cells (red nuclei), eLCs (yellow), and progenitor‐derived LCs (green) in the epidermis at 5 and 15 days after wound induction. Dashed line indicates initial wound boundary. Left : zoomed view of the wound center. Representative images from 6 mice. Representative image from 3 mice. Scale bars, 100 µm. (C) Timeline of LC number comparing cell density changes among embryonic and progenitor‐derived LCs at the wound. n = 6 mice. (D) Timeline of changes in the percentage ratio between embryonic and progenitor‐derived LCs at the wound site. n = 6 mice. (C,D) Wound area quantified 0.16 mm 2 per mouse. Data analyzed using paired two‐way ANOVA; data are mean ± s.d. * p < 0.05, ** p < 0.01. (E) Multi‐photon in vivo microscopy of dual‐labeled LC mice 22 weeks after wound induction. Dashed line indicates initial wound boundary. Left : zoomed view of the wound center. Representative image from 3 mice. Scale bars, 100 µm.

Article Snippet: Samples were then enriched for LCs by magnetic sorting following the standard protocol from the Epidermal Langerhans Cell MicroBead Kit (Miltenyi Biotec).

Techniques: Labeling, Derivative Assay, In Vivo, Microscopy

Journal: Advanced Science

Article Title: Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

doi: 10.1002/advs.76816

Figure Lengend Snippet: Monocyte‐derived Langerhans cells integrate into the existing LC network after wound closure. (A) UMAP of monocyte and Langerhans cells re‐clustering. Clusters were defined as monocytes (Mono), pre‐monocyte‐derived LCs (pre‐mLC), monocyte‐derived LCs (mLC), and embryonic LCs (eLC). Embryonic LCs subclusters were merged as “eLC” for simplicity. (B) Left : Violin plots showing the expression of top markers for monocytes ( Cd14 ) and LCs ( Cd207 ). Right : Feature plots showing the expression of the gene mentioned in the same row. (C) RNA velocity pseudotime trajectories. The direction of the black arrows reflects the changes in the surrounding cellular states. Red arrows show the general trend. (D) Dot plot of selected marker genes for monocytes, LC differentiation, and embryonic LCs. (E) Experimental design for the in vivo identification of repopulating monocyte‐derived LCs. Tamoxifen was used to label existing embryonic LCs red prior to wound induction. Tamoxifen continued to be delivered up until the expected arrival of progenitor LCs (Day 10 after wound induction). Injections were delivered every 3 days after wound induction to avoid toxicity. Revisit imaging (camera icon) was performed on Day 5 and 13. (F) Revisit multi‐photon in vivo microscopy images of a 1 mm wound from the same mouse. Top : Images show x‐y view of epithelial cells (dim red nuclei), monocytes (green), and LCs (red) in the epidermis at 5 and 13 days after wound induction. Blue frame : zoomed example of a GFP high only cell. Teal frame : zoomed example of GFP low /tdTomato low double‐positive cells. Magenta frame : zoomed example of tdTomato low only cells. Orange frame : zoomed example of a tdTomato high only cell. White arrowheads highlight the same cell within each frame. Dashed line indicates initial wound boundary. Representative images from 3 mice. Scale bars: Top : 100 µm, Colored frames : 50 µm. (G) GO plot of selected biological process terms among the top 50 results enriched in each cluster using the top 200 markers. Highlighted color shades under GO terms match the corresponding cluster colors.

Article Snippet: Samples were then enriched for LCs by magnetic sorting following the standard protocol from the Epidermal Langerhans Cell MicroBead Kit (Miltenyi Biotec).

Techniques: Derivative Assay, Expressing, Marker, In Vivo, Imaging, Microscopy

Journal: Advanced Science

Article Title: Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

doi: 10.1002/advs.76816

Figure Lengend Snippet: Cxcr2 inhibition blocks eLC wound repopulation. (A) Heatmap of normalized log2 fold change of chemokine receptor gene expression from homeostatic epithelial (KTC) and Langerhans cells (LC). Cells isolated through FACS and sequenced through bulk RNA‐seq. Each column represents an independent sample, and each row is assigned to a specific gene. Red indicates maximum expression and blue indicates minimum expression. n = 4 mice (B) Experimental design for drug treatment. Starting on wound induction day, drug was injected once a day intradermally at the ear near the wound site. Control mice received vehicle (1% DMSO) injections. Wounds were imaged at wound closure (5 days after wound induction), and candidate drugs were further analyzed for migration dynamics through time‐lapse at 2 days after wound induction. Revisit imaging (camera icon) was performed on Day 0 and 5. Timelapse imaging (video icon) was performed on Day 2. (C) Mean LC number comparing cell density at the wound in response to drug treatment. Imaging was performed 5 days after wound induction. LC density normalized to the individual mouse wound area was quantified. Data analyzed using unpaired one‐way ANOVA; n = 6 control, n = 4 BX471, n = 4 INCB3344, n = 4 DAPTA, n = 3 Cenicriviroc, n = 5 Danirixin, n = 5 SB225002, and n = 4 CXCR3 antagonist‐treated mice.; data are mean ± s.d. with each dot representing individual mice. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. (D) In vivo microscopy images show x‐y view of epithelial cells (red nuclei) and LCs (green) in the epidermis 5 days after wound induction. Top : control mouse (1% DMSO). Middle : CXCR2‐inhibited mouse (Danirixin). Bottom : CXCR2‐inhibited mouse (SB225002). Right : zoomed view of the wound center matching the image on the left. Dashed line indicates initial wound boundary. Representative images are shown. n = 6 control mice and n = 5 mice per drug‐treated group. Scale bars, 100 µm. (E) Confocal immunofluorescent images of CXCR2 expression at the epidermis during homeostasis and 2 days after wound induction. Images show x‐y view of LCs (green, MHC‐II), CXCR2 (red), and cell nuclei (blue, DAPI). Right : zoomed view in composite, green channel only, and red channel only. Dashed line indicates initial wound boundary. Representative images from 3 mice. Scale bars, 25 µm. (F) qRT‐PCR gene expression analysis of CXCR2 ligands in the skin during homeostasis (control) and 2 days after wound induction. Data analyzed using multiple unpaired two‐tailed t ‐test; n = 5 mice; data are mean ± s.d. with each dot representing individual mice. ** p < 0.01. (G) ELISA assay of CXCL1 present on wounds treated with CXCR2‐inhibitor (Danirixin) compared to control (DMSO) and homeostasis. (H) ELISA assay of CXCL2 present on wounds treated with CXCR2‐inhibitor (Danirixin) compared to control (DMSO) and homeostasis. (I) ELISA assay of CXCL3 present on wounds treated with CXCR2‐inhibitor (Danirixin) compared to control (DMSO) and homeostasis. (J) ELISA assay of CXCL5 present on wounds treated with CXCR2‐inhibitor (Danirixin) compared to control (DMSO) and homeostasis. (K) ELISA assay of CXCL7 present on wounds treated with CXCR2‐inhibitor (Danirixin) compared to control (DMSO) and homeostasis. (G–K) Data analyzed using unpaired one‐way ANOVA; n = 4 mice; data are mean ± s.d. with each dot representing individual mice. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: Samples were then enriched for LCs by magnetic sorting following the standard protocol from the Epidermal Langerhans Cell MicroBead Kit (Miltenyi Biotec).

Techniques: Inhibition, Gene Expression, Isolation, RNA Sequencing, Expressing, Injection, Control, Migration, Imaging, In Vivo, Microscopy, Quantitative RT-PCR, Two Tailed Test, Enzyme-linked Immunosorbent Assay

Journal: Advanced Science

Article Title: Dual Lineages of Langerhans Cells Cooperate to Restore the Immune Barrier after Skin Injury

doi: 10.1002/advs.76816

Figure Lengend Snippet: Monocyte‐derived Langerhans cells compensate for the loss of embryonic Langerhans cells at the wound. (A) Time‐lapse x‐y view of epithelial cells (red nuclei) and LCs (green) 2 days after wound induction. Top : control mouse 1% DMSO. Bottom : drug‐treated mouse CXCR2 (Danirixin) as shown in (Figure ). Dashed line indicates initial wound boundary. Representative images from 3 mice per group. Scale bars, 100 µm. (B) Imaris x‐y view track analysis of LCs (A) 2 days after wound induction. Colors project time (blue, 0 h; red, 6 h). Top : control mouse 1% DMSO. Bottom : drug‐treated mouse CXCR2 (Danirixin). Right : zoomed migration tracks from near the wound edge. Representative images from 3 mice per group. (C) Mean total displacement of individual epithelial cells tracks from control and CXCR2‐inhibited mice over 6 h plotted as a function of distance from the wound. n = 3 mice. (D) Mean total displacement of individual LC tracks from control and CXCR2‐inhibited mice over 6 h plotted as a function of distance from the wound. n = 3 mice. (E) Mean track displacement in the x axis of individual LC tracks from control and CXCR2‐inhibited mice over 6 h plotted as a function of distance from the wound. Calculated by comparing the start and end values on the x axis of each track. Positive change indicates movement toward the wound. n = 3 mice. (C–E) Imaging performed 2 days after wound induction. Dashed line, initial wound boundary. The displacements of migrating cell tracks were averaged every 100 µm from the initial wound. Data analyzed using unpaired two‐way ANOVA; data are mean ± s.d. * p < 0.05, **** p < 0.0001. (F) Revisit multi‐photon in vivo microscopy images of a 1 mm wound from the same mouse. Images show x‐y view of epithelial cells (dim red nuclei), embryonic LCs (orange/yellow), and progenitor‐derived LCs (green) in the epidermis at 5 ( Left ) and 17 ( Middle ) days after wound induction. Day 17 LCs at the wound quantified using Imaris spots analysis ( Right ). Top : control mouse 1% DMSO. Bottom : drug‐treated mouse CXCR2 (Danirixin). Dashed line indicates initial wound boundary. Representative images from 3 mice per group. Scale bar, 100 µm. (G) Mean LC number comparing cell density changes among embryonic LCs (eLC) and monocyte‐derived LCs (mLC) in response to CXCR2 inhibition. (H) Percentage ratio between eLCs and mLCs at the wound epidermis in response to CXCR2 inhibition. (G,H) Imaging performed 17 days after wound induction. LC density normalized to the individual mouse wound area was quantified. Data analyzed using unpaired two‐way ANOVA; n ≥3 mice; data are mean ± s.d. * p < 0.05.

Article Snippet: Samples were then enriched for LCs by magnetic sorting following the standard protocol from the Epidermal Langerhans Cell MicroBead Kit (Miltenyi Biotec).

Techniques: Derivative Assay, Control, Migration, Imaging, In Vivo, Microscopy, Inhibition

Journal: International Journal of Molecular Sciences

Article Title: Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

doi: 10.3390/ijms24043896

Figure Lengend Snippet: Ox-mtDNA activates pyroptosis. ( A ) Log10-transformed, glucose-adjusted ox-mtDNA levels from Low Risk (LR) MDS PB (n = 100) and BM plasma (n = 70), and Normal PB (n = 30). ( B ) Western blot of U937 and SKM1 cells treated with 10-fold increasing isolated mtDNA of the ND1 gene region amplified with oxidized guanosine (ox-mtDNA) for 2 h to induce Caspase-1 (arrow depicts cleaved fragment) and phosphorylated NFκB to establish dosage (representative blot of n = 3). Remaining figures, ox-mtDNA treatment is 50 ng/mL ox-mtDNA for 2 h unless otherwise stated. ( C ) Western blot of SKM1 and U937 cells treated with ox-mtDNA showing, cleavage of caspase-1 (arrow depicts cleaved fragment), and IL-1β (arrow depicts cleaved fragment) demonstrating inflammasome activation (representative blot of n = 3). ( D ) Fold change of caspase-1 activity quantified by Caspase-1 Glo ® assay in SKM1 and U937 cells treated with ox-mtDNA, (mean ± SEM of n = 5). ( E ) Fold change of LDH media release (measurement of cell death), quantified by LDH-Glo™ Cytotoxicity Assay, of SKM1 and U937 cells treated with ox-mtDNA (mean ± SEM of n = 5). ( F ) Fold change of caspase-1 activity quantified by Caspase-1 Glo ® assay in SKM1 cells pretreated with either CRISPR KO (pooled guides) for NLRP3 or 10 uM MCC950 for 48 h prior to treatment with ox-mtDNA (mean ± SEM of n = 4). ( G ) Representative confocal IF micrographs showing increased ASC specks in ox-mtDNA stimulated cells compared to untreated controls [DAPI (blue), ASC (green) (×2520)]. ( H ) Quantification of 1-to-2 μm ASC speck IF, at least 200 cells counted per group, (mean ± SEM of n = 3). ( I ) Immunoblot of ASC following chemical crosslinking, cells treated with ox-mtDNA or positive control LAN (LPS + ATP + Nigericin), arrow indicates oligomers. ( J ) Western Blot for PARP and Caspase-3. Western blot of SKM1 and U937 cells treated with ox-mtDNA, and an apoptosis positive control (A431 EGF Stimulated) showing induction of PARP1, cleavage of caspase-3 (arrow depicts cleaved fragments, representative blots of n = 3). ( K ) Fold change of caspase-1 activity quantified by Caspase-1 Glo ® assay and LDH media release quantified by LDH-Glo™ Cytotoxicity Assay in primary Normal BM-MNC cells treated with ox-mtDNA (mean ± SEM of n = 3). ( L ) Colony formation assay for hematopoiesis in Healthy BM-MNCs treated with 50 ng/mL ox-mtDNA for 14 days (representative picture). ( M ) Quantification of various hematopoietic progenitor colonies in response to treatment with 50 ng/mL of ox-mtDNA for 14 days (mean ± SEM of n = 4). In this figure, significance was assessed by either paired t -test (comparison between two groups only) or ordinary one-way ANOVA with multiple comparison analysis in GraphPad Prism. p values are shown as asterisk: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001.

Article Snippet: Apoptosis positive control was A431 Whole Cell Lysate EGF Stimulated (Rockland Immunochemicals, Inc., Limerick, PA, USA).

Techniques: Transformation Assay, Clinical Proteomics, Western Blot, Isolation, Amplification, Activation Assay, Activity Assay, Glo Assay, Cytotoxicity Assay, CRISPR, Positive Control, Colony Assay, Comparison

Journal: International Journal of Molecular Sciences

Article Title: Cell-Penetrating Delivery of Nitric Oxide by Biocompatible Dinitrosyl Iron Complex and Its Dermato-Physiological Implications

doi: 10.3390/ijms221810101

Figure Lengend Snippet: Cell viability assay of the ( a ) mouse skin melanoma (B16-F10) and ( b ) human skin keratinocyte cells (HaCaT) cells, respectively, treated with different concentrations of DNIC-2 for 24 h **** p < 0.001 compared to the group without treatment of DNIC-2 . ( c ) Cell viability assay of the reconstructed human epidermis (RhE) model treated with PBS, 5% SDS, and 50 μM of DNIC-2 , respectively. ( d ) Cell viability assay of the reconstructed human cornea-like epithelium model treated with DPBS, methyl acetate, and 50 μM of DNIC-2 , respectively.

Article Snippet: CCD-966Sk human skin fibroblasts and B16-F10 mouse skin melanoma cells were purchased from Bioresource Collection and Research Center, Food Industry Research and Development Institute (Hsinchu, Taiwan), whereas human skin keratinocyte cell line, HaCaT, was purchased from Elabscience Biotechnology Inc. (Elabscience ® EP-CL-0090, Houston, TX, USA).

Techniques: Viability Assay

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: ( A ) HER2 (diamonds), TNBC (circles), and luminal (squares and triangles) breast cancer lines were seeded into 96-well plates and treated with increasing doses of MAL3-101 for 72 hr. Viability is expressed as the average of three or more independent experiments, ± SEM. ( B ) MAL3-101-sensitive (MCF7 and MDA MB 231, denoted in blue) and resistant (MDA MB 453 and MDA MB 361, denoted in black) cells were treated with 12 µM MAL3-101 for the indicated times, and lysates were prepared and immunoblotted for cleaved caspase-3, caspase-7, and caspase-8. β-actin serves as a loading control. ( C ) The corresponding fold-increase of the indicated apoptotic markers relative to the DMSO control are plotted, ± SEM (n≥3 for cleaved caspase-3, n=3 for cleaved caspase-7, and n≥4 for cleaved caspase-8). Black asterisks correspond to statistical significance between MDA MB 231 cells (closed circle) and MDA MB 453 and MDA MB 361 (open circle and triangle, respectively), and the red asterisk represents statistical significance between MCF7 (closed triangle) and MDA MB 453 and MDA MB 361 (open circle and triangle) cells; * denotes p<0.05, ** denotes p<0.005. Figure 1—source data 1. Source data for cell viability assay and apoptotic marker accumulation in .

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques: Viability Assay, Marker

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: Breast cancer cells exhibit a range of sensitivities to MAL3-101, a specific Hsp70 inhibitor. The indicated breast cancer lines were seeded into 96-well plates and treated with increasing doses of the indicated compounds for 72 hr. Viability was measured using the CellTiter-Glo assay. IC 50 values were generate using a sigmoidal nonlinear regression with SigmaPlot 11.0. ND stands for an undetermined value. MAL3-101 sensitivities of Hsp70 inhibitor resistant cells are in bold.

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques:

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: The cell numbers and autophagy or proteasome inhibitor concentrations used for the cell viability assay in combination with increasing doses of MAL3-101 are shown. The concentrations of bortezomib, CQ, and bafilomycin to induce no greater than 30% of cell death in each line after 72 hr treatment are shown. ND stands for undetermined value.

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques: Viability Assay

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: Breast cancer cells exhibit a range of sensitivities to MAL3-101 in the presence of either autophagy or proteasome inhibitors. Cells were seeded into 96-well plates and treated with increasing doses of MAL3-101 in the presence or absence of subcritical doses of bortezomib (proteasome inhibitor), or CQ or bafilomycin (autophagy inhibitors) for 72 hr. Viability was measured using the CellTiter-Glo assay. IC 50 values were generate using a sigmoidal nonlinear regression with SigmaPlot 11.0. ND stands for undetermined value. MAL3-101 resistant cells are highlighted in yellow.

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques:

Journal: Arthritis Research & Therapy

Article Title: Synergistic role of c-Myc and ERK1/2 in the mitogenic response to TGFβ-1 in cultured rat nucleus pulposus cells

doi: 10.1186/ar2567

Figure Lengend Snippet: Effect of transforming growth factor β1 (TGFβ1) treatment on mRNA expression in different cell types (a), Cells were treated with or without 5 ng/mL TGFβ1 for 24 h . The expression of c-myc in nucleus pulposus cells (NP), in articular chondrocytes (AC) and keratinocytes (KT) are presented. The expression of p15 , p21 and p27 in NP was also determined. Time course of c-myc expression in NP treated with 5 ng/mL TGFβ1 (b). The graph shows the relative intensities of c-myc bands normalized for β-actin levels by densitographic analysis. Incubation for 24 h with medium containing various concentrations of fetal bovine serum (FBS) did not alter the level of c-myc expression in NP (c). The reverse transcription-polymerase chain reaction (RT-PCR) was performed on total RNA extracted from the cells. β-actin was used as an internal control.

Article Snippet: Cryopreserved primary passage rat epidermal keratinocytes were obtained from Cell Applications Inc. (San Diego, CA, USA) and maintained in growth medium (Cell Applications Inc.).

Techniques: Expressing, Incubation, Reverse Transcription, Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Control

Journal: Clinical Cancer Research

Article Title: Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth

doi: 10.1158/1078-0432.CCR-23-3110

Figure Lengend Snippet: Stochastic conjugation of cetuximab to CDK inhibitor and ADC internalization in live breast cancer cells. A, Flow cytometric evaluation of surface EGFR expression (TNBC: MDA-MB-468, HCC1143, HCC1806, MDA-MB-231, HCC1937, SUM149, and CAL51; HER2+: SKBR3; ER+: MCF7, T47D; nontumorigenic epithelial cell model: MCF10A; immune cell model: human B lymphocytes RPMI8866, RPMI8226, and monocytic cell line U937; human primary melanocyte: melanocyte). B, EGFR mRNA expression from the Cancer Cell Line Encyclopedia database showed a positive correlation with surface EGFR measured by flow cytometry in A (Spearman’s rank coefficient, r = 0.723). A high level of correlation was found between EGFR and cyclin E ( r = 0.738), but not with cyclin A or CDK2. Nonsignificant P values are marked as NS. C, Top, Schematic diagram of stochastic ADC conjugation by antibody reduction with TCEP and then conjugation to SNS-032 via MC-Val–Ala-PAB. Middle, HIC analysis confirmed an average DAR of 4.4. Bottom, SEC trace indicates negligible ADC aggregation and minimal free linker–payload (less than 0.8%). D, Surface plasmon resonance analysis demonstrated similar binding affinity ( K D ) for cetuximab (0.73 nmol/L) and ADC (1.28 nmol/L). Isotype IgG1 and isotype ADC showed no measurable binding. E, Monitoring internalization of Fabfluor-pH-labeled cetuximab, ADC, or isotype control (10 nmol/L) by Incucyte live-cell imaging. Phase and red fluorescence time-course images were captured for 24 hours. Images of internalized antibody display in cytosolic, low pH lysosomal vesicle-associated red fluorescence in cells. Scale bar, 0.2 mm. F, Cells were seeded in Matrigel for 5 days, allowing the formation of spheroids. Fabfluor-pH-labeled antibodies or ADC (10 nmol/L) were introduced in the Matrigel and showed rapid internalization in EGFR-high MDA-MB-468 and MDA-MB-231, whereas EGFR-low CAL51 displayed little red fluorescence signals. A low level of internalization was observed for isotype or isotype-ADC controls. Scale bar, 0.5 mm. P values determined by two-tailed unpaired t test of three independent experiments compared with isotype control.

Article Snippet: Human primary epidermal melanocytes were cultured in Melanocyte Growth Medium (Cell Applications Inc.).

Techniques: Conjugation Assay, Expressing, Flow Cytometry, SPR Assay, Binding Assay, Labeling, Control, Live Cell Imaging, Fluorescence, Two Tailed Test